Seer, Inc. (SEER)
NASDAQ: SEER · Real-Time Price · USD
1.720
-0.360 (-17.31%)
At close: Feb 27, 2026, 4:00 PM EST
1.750
+0.030 (1.74%)
After-hours: Feb 27, 2026, 5:28 PM EST
Seer, Inc. Market Cap
Seer, Inc. has a market cap or net worth of $96.75 million as of February 27, 2026. Its market cap has decreased by -27.08% in one year.
Market Cap
96.75M
Enterprise Value
-65.49M
1-Year Change
-27.08%
Ranking
Category
Stock Price
$1.72
Market Cap Chart
Since the IPO on December 4, 2020, Seer, Inc.'s market cap has decreased from $3.27B to $96.75M, a decrease of -97.04%. That is a compound annual growth rate of -48.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 96.75M | -6.01% |
| Dec 31, 2025 | 102.94M | -24.43% |
| Dec 31, 2024 | 136.21M | 10.01% |
| Dec 29, 2023 | 123.82M | -65.92% |
| Dec 30, 2022 | 363.32M | -74.19% |
| Dec 31, 2021 | 1.41B | -57.77% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 4, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| MacroGenics | 125.88M |
| Spero Therapeutics | 124.51M |
| Immunic | 123.64M |
| Inovio Pharmaceuticals | 122.98M |
| Coya Therapeutics | 116.77M |
| Oncolytics Biotech | 115.14M |
| Korro Bio | 114.61M |
| Agenus | 114.44M |